Blog

Contract manufacturer Jabil announced today that it has received accreditation for its plastic injection molding operation in Tijuana from the MedAccred program. Its the first company in Mexico to earn this certification.

MedAccred claims to be the only industry-managed supply chain oversight program for key critical manufacturing processes in the medical device industry. The audit requirements that must be met to achieve accreditation are set forth by MedAccred subscribing members, which include Bausch Health, Baxter, BD, Boston Scientific, Edwards Lifesciences, Johnson & Johnson, Medtronic, Philips, Roche Diagnostics, and Stryker.

“Eight years ago, Jabil integrated our sites in Tijuana to offer over 358,000 square feet of manufacturing space,” said Carlos Padilla, Jabil Quality Director for Latin America, in a prepared statement. “Earning the first MedAccred accreditation in Mexico for this massive, state-of-the-art site opens new opportunities for healthcare companies to improve product development and production with a high-quality, global leader. This accreditation — involving meticulous audits and inspections — confirms the high quality of Jabil’s proprietary processes and supply chain management,” said Padilla.

The MedAccred program was established in 2012 and is administered by Performance Review Institute (PRI), a not-for-profit organization that also supports the longstanding Nadcap accreditation program for the aerospace industry. Since its founding, MedAccred has developed audit systems for cable and wire harness production, heat treatments, plastics, printed circuit board assemblies, sterilization, and welding. Audit criteria for injection molding were first released in June 2016. US-based injection molders that have earned accreditation since then include BMP Medical, Hoffer Plastics, PTA Plastics, and Intertech Plastics.